|
|
|
Volumn 23, Issue 5 SUPPL. 11, 1996, Pages 41-45
|
|
Paclitaxel and carboplatin for advanced breast cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
PACLITAXEL;
THROMBOPOIETIN;
ADULT;
ADVANCED CANCER;
AGED;
AREA UNDER THE CURVE;
ARTICLE;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DOSE CALCULATION;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
QUALITY OF LIFE;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
AREA UNDER CURVE;
BLOOD PLATELETS;
BREAST NEOPLASMS;
CARBOPLATIN;
CLINICAL TRIALS, PHASE II;
DRUG ADMINISTRATION SCHEDULE;
DRUG TOLERANCE;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
LUNG NEOPLASMS;
NEOPLASM METASTASIS;
OVARIAN NEOPLASMS;
PACLITAXEL;
QUALITY OF LIFE;
THROMBOPOIETIN;
|
|
EID: 0029847137
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (19)
|
|
References (0)
|
